To hear about similar clinical trials, please enter your email below

Trial Title: Different Modalities of Management of Odontogenic Keratocysts

NCT ID: NCT06133764

Condition: Odontogenic Cysts

Conditions: Official terms:
Odontogenic Cysts
Ethanol
Acetic Acid
Pharmaceutical Solutions

Conditions: Keywords:
Odontogenic cysts
Odontogenic Keratocysts

Study type: Interventional

Study phase: N/A

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: The patents will be divided into five groups according to the treatment modalities used to treat their odontogenic cysts

Primary purpose: Treatment

Masking: Triple (Participant, Investigator, Outcomes Assessor)

Masking description: The patients, investigators, and outcomes assessor will not be informed about the study

Intervention:

Intervention type: Procedure
Intervention name: Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+CS + PO)
Description: The enucleation procedures, which were meticulously carried out in order to remove the odontogenic keratocyst in one piece without breaking its lining or leaving any epithelial remnants.The peripheral ostectomy treatment will be carried out with a large spherical bur and plenty of irrigation.After filling the bone cavity with more sterile gauze, the Carnoy's solution was slowly injected into it with a plastic syringe. The gauze was continuously injected with CS until it was fully saturated without leaking too much into the surrounding tissues. The CS was held in place for 3 minutes.
Arm group label: Enucleation + Peripheral ostectomy + Carnoy's solution chemical cauterization (E+ PO+ CS)

Other name: (E + PO+ CS)

Intervention type: Procedure
Intervention name: Decompression/ marsupialization (D/M)
Description: A surgical window will be created in the cyst wall to drain the contents while retaining continuity between the cyst and the oral cavity
Arm group label: Decompression/marsupialization (D/M)

Other name: D/M

Intervention type: Procedure
Intervention name: Enucleation (E)
Description: The enucleation will be accomplished in the same manner that it will be performed in the group of Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+ PO+ CS).
Arm group label: Enucleation (E)

Other name: E

Intervention type: Procedure
Intervention name: Enucleation+Carnoy's solution (E+CS)
Description: Both enucleation and Carnoy's solution will be carried out as planned in the group Enucleation+ Peripheral Ostectomy+Carnoy's solution chemical cauterization (E+ PO+ CS).
Arm group label: Enucleation+Carnoy's solution (E+CS)

Other name: (E+CS)

Intervention type: Procedure
Intervention name: Enucleation+ Peripheral Ostectomy (E+ PO)
Description: Both enucleation and peripheral ostectomy will be carried out as planned in the group Enucleation+ Peripheral Ostectomy+ Carnoy's solution chemical cauterization (E+ PO+ CS).
Arm group label: Enucleation+ Peripheral Ostectomy (E+PO)

Other name: (E+PO)

Summary: Background The odontogenic keratocysts (OKCs) have been one of the maxillofacial region's most contentious pathological phenomena. Decompression/marsupialization (D/M), enucleation (E), enucleation + chemical cauterization with Carnoy's solution (E+CS), enucleation + peripheral ostectomy (E + PO), as opposed to enucleation + chemical cauterization with Carnoy's solution + peripheral ostectomy (E + CS + PO), were used during surgery to ensure that no epithelial remnants were left behind. Rationale Through the management of OKC a recurrence could occur, the effectiveness of Decompression/marsupialization (D/M), Enucleation (E), Enucleation+Carnoy's solution chemical cauterization (E+CS), Enucleation+peripheral ostectomy (E+PO), Enucleation+Carnoy's solution chemical cauterization + peripheral ostectomy (E+CS + PO), will be analyzed

Detailed description: Since the middle of the 20th century, the odontogenic keratocyst (OKC) has been one of the maxillofacial region's most contentious pathological phenomena. It was initially misdiagnosed as a primordial cyst. After that, because of its severe clinical behavior and tendency to recur, it was no longer considered to be a part of its classification, also known as a odontogenic tumor. Then, In 2017, the OKC are re-classified as a cystic lesion. But still there is debate about their management. So, this study will be enrolled with the following objectives: to describe how odontogenic keratocysts are managed, to Discover the most favorable approach to manage OKC with the need to stop it from happening again To categorize the odontogenic keratocyst management outcomes into to the subsequent groups: (1) total resolution, (2) partial resolution; (3) Recurrence.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - All odontogenic keratocysts that are treated by the following surgical treatment modalities: 1. Enucleation followed by peripheral ostectomy and Carnoy's solution 2. Decompression/ marsupialization 3. Enucleation 4. Enucleation and Carnoy's solution 5. Enucleation and Peripheral Ostectomy - Follow-up period 10 years Exclusion Criteria: - Cases treated with resection - Cases showed neoplastic transformation in their pathology - Cyst Like lesions

Gender: All

Minimum age: 10 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: College of Dentistry, Qassim University

Address:
City: Buraydah
Zip: 1162
Country: Saudi Arabia

Status: Recruiting

Contact:
Last name: Ghada A Khalifa, Professor

Phone: 504840248

Phone ext: +966
Email: dean.office@qudent.org

Contact backup:
Last name: Alaa K Alanzi, Student

Phone: 532417017

Phone ext: +966
Email: 411216430@qu.edu.sa

Investigator:
Last name: Alaa K Alanzi, Student
Email: Principal Investigator

Start date: February 24, 2023

Completion date: January 31, 2025

Lead sponsor:
Agency: Qassim University
Agency class: Other

Collaborator:
Agency: Al-Azhar University
Agency class: Other

Source: Qassim University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06133764

Login to your account

Did you forget your password?